<DOC>
	<DOC>NCT00827255</DOC>
	<brief_summary>The objective of this retrospective chart review is to evaluate the patient characteristics, treatment variations and efficacy of a second trial of Cyclosporine Ophthalmic Emulsion 0.05% therapy in chronic dry eye patients who were initially treated with Cyclosporine Ophthalmic Emulsion 0.05% but discontinued use after less than 12 weeks of treatment.</brief_summary>
	<brief_title>Physician's Evaluation of Cyclosporine Ophthalmic Emulsion 0.05%</brief_title>
	<detailed_description />
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Adults &gt;16 years of age Dry eye patients Subject with history of less than 12 weeks of initial RESTASIS® treatment Subject started second trial of RESTASIS® treatment prior to June 1, 2008 First day of second trial of RESTASIS® started ≥ 4 weeks after the last day of previous RESTASIS® treatment Patients with Contact Lens Intolerance Patients with Ocular Rosacea</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>